GingiCaine Fusion

Product NDC
10129-040
11-digit product format
101290040
Labeler code
10129
Product ID
10129-040_d292edc9-652b-b62d-e053-2995a90a635c
Type
HUMAN OTC DRUG
Nonproprietary name
Benzocaine
Dosage form
GEL
Route
TOPICAL
Labeler
Gingi-Pak a Division of the Belport
Application
part356
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2021-06-04
Marketing end
0000-00-00
Substance
BENZOCAINE
Active strength
20 g/100g
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
4d7a96d5-8256-4268-9a6c-25ea66d321feProduct name120180814
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10129-040-01GingiCaine Fusion14 g in 1 JARGEL142
10129-040-20GingiCaine Fusion1.2 g in 1 SYRINGE, PLASTICGEL1.22
10129-040-20GingiCaine Fusion20 in 1 BOXGEL202

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10129-040GINGICAINE FUSION (BENZOCAINE) GEL [GINGI-PAK A DIVISION OF THE BELPORT]2Legacy NDC, 3 package rows20211209_a1f3c4d4-048c-7c3c-e053-2995a90a1b35.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
10129-040-011012900400114 g in 1 JAR (10129-040-01) 14 g2021-06-040000-00-00NoNoCurrent
10129-040-201012900402020 SYRINGE, PLASTIC in 1 BOX (10129-040-20) > 1.2 g in 1 SYRINGE, PLASTIC2021-06-040000-00-00NoNoCurrent